Our study aimed to investigate the role of Nrf2 and NF-κB in diabetic neuropathy and to summarize the therapeutic outcomes of moxibustion targeted at Nrf2–NF-κB in diabetic neuropathy. This evidence concerns the gene NFKB1 and diabetic neuropathy.